{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:27:43Z","timestamp":1784294863519,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s41030-025-00300-7","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T04:47:00Z","timestamp":1750394820000},"page":"519-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Evolution of the Indwelling Pleural Catheter"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9934-172X","authenticated-orcid":false,"given":"Abdulla","family":"Baguneid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thisarana","family":"Wijayaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Aujayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"300_CR1","unstructured":"Summary of Safety and Effectives Denver PleurX Pleural Catheter Kit Denver Home Drainage Kit. Rockville, Food and Drug Administration 1997."},{"key":"300_CR2","unstructured":"PleurX Pleural Catheter and Drainage Kits. Rockville, Food and Drug Administration, 2001"},{"issue":"Suppl 3","key":"300_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219371","volume":"78","author":"R Asciak","year":"2023","unstructured":"Asciak R, Bedawi EO, Bhatnagar R, Clive AO, Hassan M, Lloyd H, et al. British Thoracic Society clinical statement on pleural procedures. Thorax. 2023;78(Suppl 3): s43.","journal-title":"Thorax"},{"key":"300_CR4","unstructured":"https:\/\/www.youtube.com\/watch?v=dJW2tM1RPcY accessed on 26th March 2025"},{"key":"300_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1136\/thoraxjnl-2013-204563","volume":"69","author":"R Bhatnagar","year":"2014","unstructured":"Bhatnagar R, Reid ED, Corcoran JP, et al. Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice. Thorax. 2014;69:959\u201361.","journal-title":"Thorax"},{"issue":"3","key":"300_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.chest.2016.10.052","volume":"151","author":"M Patil","year":"2017","unstructured":"Patil M, Dhillon SS, Attwood K, Saoud M, Alraiyes AH, Harris K. Management of benign pleural effusions using indwelling pleural catheters: a systematic review and meta-analysis. Chest. 2017;151(3):626\u201335.","journal-title":"Chest"},{"key":"300_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.136994","author":"ME Roberts","year":"2010","unstructured":"Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010. https:\/\/doi.org\/10.1136\/thx.2010.136994.","journal-title":"Thorax"},{"key":"300_CR8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/thorax-2023-220304","volume":"78","author":"ME Roberts","year":"2023","unstructured":"Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society guideline for pleural disease. Thorax. 2023;78:1143\u201356.","journal-title":"Thorax"},{"key":"300_CR9","unstructured":"Hallifax R, Wrightson JM, Bibby A, et al. Pleural Services during the COVID-19 Pandemic. British Thoracic Society. https:\/\/www.brit-thoracic.org.uk\/document-library\/qualityimprovement\/covid-19\/pleural-services-during-covid-19- pandemic\/ (accessed on 17th October 2024)"},{"issue":"22","key":"300_CR10","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1001\/jama.2012.5535","volume":"307","author":"HE Davies","year":"2012","unstructured":"Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307(22):2383\u20139. https:\/\/doi.org\/10.1001\/jama.2012.5535.","journal-title":"JAMA"},{"key":"300_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lungcan.2017.01.019","volume":"108","author":"RC Boshuizen","year":"2017","unstructured":"Boshuizen RC, Noort V, Burgers JA, Herder GJM, Hashemi SMS, Hiltermann TJN, et al. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). Lung Cancer. 2017;108:9\u201314.","journal-title":"Lung Cancer"},{"issue":"19","key":"300_CR12","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.2017.17426.PMID:29164255;PMCID:PMC5820726","volume":"318","author":"R Thomas","year":"2017","unstructured":"Thomas R, Fysh ETH, Smith NA, Lee P, Kwan BCH, Yap E, Horwood FC, Piccolo F, Lam DCL, Garske LA, Shrestha R, Kosky C, Read CA, Murray K, Lee YCG. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial. JAMA. 2017;318(19):1903\u201312. https:\/\/doi.org\/10.1001\/jama.2017.17426.PMID:29164255;PMCID:PMC5820726.","journal-title":"JAMA"},{"key":"300_CR13","unstructured":"My pleural effusion journey.\u00a0https:\/\/mypleuraleffusionjourney.com\/\u00a0(accessed on 20 March 2025)"},{"issue":"9","key":"300_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.arbres.2023.06.007","volume":"59","author":"JM Porcel","year":"2023","unstructured":"Porcel JM, Cordovilla R, Tazi-Mezalek R, Barrios-Barreto D, P\u00e9rez-Pallar\u00e9s J, Novais e Bastos H, et al. Efficacy and safety of indwelling catheter for malignant pleural effusions related to timing of cancer therapy: a systematic review. Arch Bronconeumol. 2023;59(9):566\u201374.","journal-title":"Arch Bronconeumol"},{"key":"300_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2009.06.133","author":"D Borgeson","year":"2009","unstructured":"Borgeson D, Defranchi S, Lam C, Lin G, Iii F. Chronic indwelling pleural catheters reduce hospitalizations in advanced heart failure with refractory pleural effusions. J Card Fail. 2009. https:\/\/doi.org\/10.1016\/j.cardfail.2009.06.133.","journal-title":"J Card Fail"},{"issue":"5","key":"300_CR16","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1378\/chest.13-0331","volume":"144","author":"N Srour","year":"2013","unstructured":"Srour N, Potechin R, Amjadi K. Use of indwelling pleural catheters for cardiogenic pleural effusions. Chest. 2013;144(5):1603\u20138.","journal-title":"Chest"},{"key":"300_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.02.027","author":"RK Freeman","year":"2014","unstructured":"Freeman RK, Ascioti AJ, Dake M, Mahidhara RS. A propensity-matched comparison of pleurodesis or tunneled pleural catheter for heart failure patients with recurrent pleural effusion. Ann Thorac Surg. 2014. https:\/\/doi.org\/10.1016\/j.athoracsur.2014.02.027.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"300_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1513\/AnnalsATS.201507-471BC","volume":"13","author":"A Majid","year":"2016","unstructured":"Majid A, Kheir F, Fashjian M, Chatterji S, Fernandez-Bussy S, Ochoa S, et al. Tunneled pleural catheter placement with and without talc poudrage for treatment of pleural effusions due to congestive heart failure. Ann Am Thorac Soc. 2016;13(2):212\u20136.","journal-title":"Ann Am Thorac Soc"},{"key":"300_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000501","author":"N Frost","year":"2020","unstructured":"Frost N, Ruwwe-Gl\u00f6senkamp C, Raspe M, Br\u00fcnger M, Temmesfeld-Wollbr\u00fcck B, Suttorp N, et al. Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre\u2019s 10 years of experience. Open Respir Res. 2020. https:\/\/doi.org\/10.1136\/bmjresp-2019-000501.","journal-title":"Open Respir Res"},{"issue":"2","key":"300_CR20","doi-asserted-by":"publisher","first-page":"2101362","DOI":"10.1183\/13993003.01362-2021","volume":"59","author":"SP Walker","year":"2022","unstructured":"Walker SP, Bintcliffe O, Keenan E, Stadon L, Evison M, Haris M, et al. Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions. Eur Respir J. 2022;59(2):2101362.","journal-title":"Eur Respir J"},{"issue":"2","key":"300_CR21","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.21037\/jtd-23-1731","volume":"16","author":"T Wijayaratne","year":"2024","unstructured":"Wijayaratne T, Yousuf A, Panchal R. Cardiac related pleural effusions: a narrative review. J Thorac Dis. 2024;16(2):1674\u201386.","journal-title":"J Thorac Dis"},{"issue":"1","key":"300_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.chest.2021.08.043","volume":"161","author":"CR Gilbert","year":"2022","unstructured":"Gilbert CR, Shojaee S, Maldonado F, Yarmus LB, Bedawi E, Feller-Kopman D, Rahman NM, Akulian JA, Gorden JA. Pleural interventions in the management of hepatic hydrothorax. Chest. 2022;161(1):276\u201383.","journal-title":"Chest"},{"key":"300_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000058","author":"JM Porcel","year":"2014","unstructured":"Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulmonary Med. 2014. https:\/\/doi.org\/10.1097\/MCP.0000000000000058.","journal-title":"Curr Opin Pulmonary Med"},{"issue":"6","key":"300_CR24","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1513\/AnnalsATS.201510-688BC","volume":"13","author":"A Chen","year":"2016","unstructured":"Chen A, Massoni J, Jung D, Crippin J. Indwelling tunneled pleural catheters for the management of hepatic hydrothorax. A pilot study. Ann Am Thorac Soc. 2016;13(6):862\u20136.","journal-title":"Ann Am Thorac Soc"},{"key":"300_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.07.001","author":"C Kniese","year":"2019","unstructured":"Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling pleural catheters in hepatic hydrothorax. Chest. 2019. https:\/\/doi.org\/10.1016\/j.chest.2018.07.001.","journal-title":"Chest"},{"issue":"3","key":"300_CR26","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.chest.2018.08.1034","volume":"155","author":"S Shojaee","year":"2019","unstructured":"Shojaee S, Rahman N, Haas K, Kern R, Leise M, Alnijoumi M, et al. Indwelling tunneled pleural catheters for refractory hepatic hydrothorax in patients with cirrhosis: a multicenter study. Chest. 2019;155(3):546\u201353.","journal-title":"Chest"},{"key":"300_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(20)34296-7","author":"I Bartnicki-Navarrete","year":"2020","unstructured":"Bartnicki-Navarrete I, Valladares A, Bola\u00f1os-Morales F, Torre G, P\u00e1ez-Zayas V, Garc\u00eda-Ju\u00e1rez I. Tu1683 indwelling pleural catheters versus serial thoracentesis in the treatment of refractory hepatic hydrothorax: a multicenter cohort study. Gastroenterology. 2020. https:\/\/doi.org\/10.1016\/S0016-5085(20)34296-7.","journal-title":"Gastroenterology"},{"issue":"3","key":"300_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/LBR.0000000000000823","volume":"29","author":"A Avula","year":"2022","unstructured":"Avula A, Acharya S, Anwar S, Narula N, Chalhoub M, Maroun R, et al. Indwelling pleural catheter (IPC) for the management of hepatic hydrothorax: the known and the unknown. J Bronchology Interv Pulmonol. 2022;29(3):179\u201385.","journal-title":"J Bronchology Interv Pulmonol"},{"key":"300_CR29","unstructured":"www.isrctn.com\/ISRCTN10499680 accessed 20th March 2025"},{"issue":"9","key":"300_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","volume":"6","author":"S Muruganandan","year":"2018","unstructured":"Muruganandan S, Azzopardi M, Fitzgerald DB, Shrestha R, Kwan BCH, Lam DCL, et al. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med. 2018;6(9):671\u201380.","journal-title":"Lancet Respir Med"},{"issue":"8","key":"300_CR31","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","volume":"195","author":"MM Wahidi","year":"2017","unstructured":"Wahidi MM, Reddy C, Yarmus L, Feller-Kopman D, Musani A, Shepherd RW, et al. Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial. Am J Respir Crit Care Med. 2017;195(8):1050\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"300_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejcts.2007.10.002","volume":"33","author":"WH Warren","year":"2008","unstructured":"Warren WH, Kim AW, Liptay MJ. Identification of clinical factors predicting Pleurx\u00ae catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg. 2008;33(1):89\u201394.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"14","key":"300_CR33","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","volume":"378","author":"R Bhatnagar","year":"2018","unstructured":"Bhatnagar R, Keenan Emma K, Morley Anna J, Kahan Brennan C, Stanton Andrew E, Haris M, et al. Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med. 2018;378(14):1313\u201322.","journal-title":"N Engl J Med"},{"key":"300_CR34","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2019.OA493","author":"DB Fitzgerald","year":"2019","unstructured":"Fitzgerald DB, Muruganandan S, Stanley C, Badiei A, Murray K, Read CA, et al. EPIToME (Early Pleurodesis via IPC with Talc for Malignant Effusion): Evaluation of a new management algorithm. Europ Resp J. 2019. https:\/\/doi.org\/10.1183\/13993003.congress-2019.OA493.","journal-title":"Europ Resp J"},{"key":"300_CR35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01215-2022","author":"P Sivakumar","year":"2024","unstructured":"Sivakumar P, Fitzgerald DB, Ip H, Rao D, West A, Noorzad F, et al. The impact of outpatient versus inpatient management on health-related quality of life outcomes for patients with malignant pleural effusion: the OPTIMUM randomised clinical trial. Eur Respir J. 2024. https:\/\/doi.org\/10.1183\/13993003.01215-2022.","journal-title":"Eur Respir J"},{"issue":"9","key":"300_CR36","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.21037\/jtd.2016.08.55","volume":"8","author":"R Krochmal","year":"2016","unstructured":"Krochmal R, Reddy C, Yarmus L, Desai NR, Feller-Kopman D, Lee HJ. Patient evaluation for rapid pleurodesis of malignant pleural effusions. J Thorac Dis. 2016;8(9):2538\u201343.","journal-title":"J Thorac Dis"},{"key":"300_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-001682","author":"A Dipper","year":"2023","unstructured":"Dipper A, Sundaralingam A, Hedley E, Tucker E, White P, Bhatnagar R, et al. The randomised thoracoscopic talc poudrage+indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled trial. Open Respir Res. 2023. https:\/\/doi.org\/10.1136\/bmjresp-2023-001682.","journal-title":"Open Respir Res"},{"issue":"10","key":"300_CR38","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1513\/AnnalsATS.202111-1301OC","volume":"19","author":"JB Shrager","year":"2022","unstructured":"Shrager JB, Bhatnagar R, Kearney CT, Retzlaff NP, Cohen E, Stanton AE, et al. Silver nitrate-coated versus standard indwelling pleural catheter for malignant effusions: the swift randomized trial. Ann Am Thorac Soc. 2022;19(10):1722\u20139.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"300_CR39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1378\/chest.128.2.684","volume":"128","author":"S Paschoalini Mda","year":"2005","unstructured":"Paschoalini Mda S, Vargas FS, Marchi E, Pereira JR, Jatene FB, Antonangelo L, et al. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest. 2005;128(2):684\u20139.","journal-title":"Chest"},{"key":"300_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/LBR.0000000000000599","author":"I Matus","year":"2019","unstructured":"Matus I, Ho P. Ambulatory iodopovidone instillation via indwelling pleural catheters for malignant pleural effusions. J Bronchol Intervent Pulmonol. 2019. https:\/\/doi.org\/10.1097\/LBR.0000000000000599.","journal-title":"J Bronchol Intervent Pulmonol"},{"issue":"4","key":"300_CR41","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0145-2023","volume":"19","author":"LM Piggott","year":"2024","unstructured":"Piggott LM, Hayes C, Greene J, Fitzgerald DB. Malignant pleural disease. Breathe. 2024;19(4): 230145.","journal-title":"Breathe"},{"issue":"7","key":"300_CR42","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","volume":"198","author":"DJ Feller-Kopman","year":"2018","unstructured":"Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK, Henry T, et al. Management of malignant pleural effusions an Official ATS\/STS\/STR Clinical practice guideline. Am J Respirat Critical Care Med. 2018;198(7):839\u201349.","journal-title":"Am J Respirat Critical Care Med"},{"issue":"5","key":"300_CR43","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1164\/ajrccm.162.5.ats8-00","volume":"162","author":"Management of malignant pleural effusions","year":"2000","unstructured":"Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000;162(5):1987\u20132001.","journal-title":"Am J Respir Crit Care Med"},{"key":"300_CR44","doi-asserted-by":"crossref","unstructured":"Thakkar D, Lamb CR, Quadri SM. Using a Novel Digital Pleural Drainage Device: A Proof of Concept. C23 Pleural Disease, Cf, And Other Magical Creatures. American Thoracic Society International Conference Abstracts: American Thoracic Society; 2019. p. A4338-A","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A4338"},{"key":"300_CR45","doi-asserted-by":"crossref","unstructured":"Yousuf A, Hinchcliffe F, Johnstone S, Mohammad S, Sudhir R, Panchal R. S139\u2005Experience of using a novel digital drainage system via an indwelling pleural catheter (IPC): a case series. Thorax. 2023;78(Suppl 4):A101-A2","DOI":"10.1136\/thorax-2023-BTSabstracts.145"},{"key":"300_CR46","doi-asserted-by":"crossref","unstructured":"Wijayaratne T, Hinchcliffe F, Rizvi S, Mavilakandy A, Johnstone S, Sudhir R, et al. S26\u2005Feasibility and effectiveness of the Passio\u2122 digital drainage system in reducing chest pain during IPC pleural drainage. Thorax. 2024;79(Suppl 2):A24-A5","DOI":"10.1136\/thorax-2024-BTSabstracts.32"},{"key":"300_CR47","unstructured":"www.isrctn.com\/ISRCTN16390322 accessed 20th March 2025"},{"key":"300_CR48","doi-asserted-by":"crossref","unstructured":"Welch H, Barton E, Beech E, Patole S, Stadon L, Maskell N. Does a novel Indwelling Pleural Catheter drainage system improve patient experience? European Respiratory Journal.62(suppl 67):OA1563","DOI":"10.1183\/13993003.congress-2023.OA1563"},{"issue":"6","key":"300_CR49","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S2213-2600(24)00111-5","volume":"12","author":"KG Blyth","year":"2024","unstructured":"Blyth KG, Adusumilli PS, Astoul P, Darlison L, Lee YCG, Mansfield AS, et al. Leveraging the pleural space for anticancer therapies in pleural mesothelioma. Lancet Respir Med. 2024;12(6):476\u201383.","journal-title":"Lancet Respir Med"},{"key":"300_CR50","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/1097-0142(19910415)67:8<2033::AID-CNCR2820670804>3.0.CO;2-8","volume":"67","author":"C Boutin","year":"1991","unstructured":"Boutin C, Viallat JR, van Zandwijk N, et al. Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma. Cancer. 1991;67:2033\u20137.","journal-title":"Cancer"},{"key":"300_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1378\/chest.103.1.209","volume":"103","author":"P Astoul","year":"1993","unstructured":"Astoul P, Viallat J-R, Laurent JC, Brandely M, Boutin C. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion. Chest. 1993;103:209\u201313.","journal-title":"Chest"},{"key":"300_CR52","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/1097-0142(19941101)74:9<2460::AID-CNCR2820740912>3.0.CO;2-N","volume":"74","author":"C Boutin","year":"1994","unstructured":"Boutin C, Nussbaum E, Monnet I, et al. Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer. 1994;74:2460\u20137.","journal-title":"Cancer"},{"key":"300_CR53","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2099::AID-CNCR8>3.0.CO;2-3","volume":"83","author":"P Astoul","year":"1998","unstructured":"Astoul P, Picat-Joossen D, Viallat J-R, Boutin C. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma. Cancer. 1998;83:2099\u2013104.","journal-title":"Cancer"},{"issue":"5","key":"300_CR54","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.ymthe.2018.02.015","volume":"26","author":"C Aggarwal","year":"2018","unstructured":"Aggarwal C, Haas AR, Metzger S, Aguilar LK, Aguilar-Cordova E, Manzanera AG, et al. Phase I study of intrapleural gene-mediated cytotoxic immunotherapy in patients with malignant pleural effusion. Mol Ther. 2018;26(5):1198\u2013205.","journal-title":"Mol Ther"},{"key":"300_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.lungcan.2020.10.007","volume":"150","author":"SJ Danson","year":"2020","unstructured":"Danson SJ, Conner J, Edwards JG, Blyth KG, Fisher PM, Muthana M, et al. Oncolytic herpesvirus therapy for mesothelioma - A phase I\/IIa trial of intrapleural administration of HSV1716. Lung Cancer. 2020;150:145\u201351.","journal-title":"Lung Cancer"},{"issue":"1","key":"300_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/1759-7714.13238","volume":"11","author":"K Nie","year":"2020","unstructured":"Nie K, Zhang Z, You Y, Zhuang X, Zhang C, Ji Y. A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer. Thorac Cancer. 2020;11(1):8\u201314.","journal-title":"Thorac Cancer"},{"key":"300_CR57","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.3019","author":"DA Fennell","year":"2024","unstructured":"Fennell DA, Dulloo S, Lord S, Thistlethwaite F, Blyth KG, Szlosarek PW, et al. First-in-human phase I clinical trial of RSO-021, a first-in-class covalent inhibitor of mitochondrial peroxiredoxin 3 (PRX3), in patients with malignant pleural effusion due to mesothelioma and other advanced solid tumors (MITOPE). J Clin Oncol. 2024. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.3019.","journal-title":"J Clin Oncol"},{"key":"300_CR58","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS8124","author":"S Dulloo","year":"2024","unstructured":"Dulloo S, Lord S, Fennell DA, Thistlethwaite F, Maskell N, Popat S, et al. Phase 2 study to evaluate the novel mitochondrial PRX3 inhibitor, RSO-021, as an intrapleural monotherapy and in combination with IV paclitaxel in patients with malignant pleural effusion due to mesothelioma or another advanced solid tumor. J Clin Oncol. 2024. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.TPS8124.","journal-title":"J Clin Oncol"},{"issue":"4","key":"300_CR59","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/resp.12962","volume":"22","author":"JA Olfert","year":"2017","unstructured":"Olfert JA, Penz ED, Manns BJ, Mishra EK, Davies HE, Miller RF, et al. Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion. Respirology. 2017;22(4):764\u201370.","journal-title":"Respirology"},{"issue":"6","key":"300_CR60","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1513\/AnnalsATS.201908-615OC","volume":"17","author":"M Shafiq","year":"2020","unstructured":"Shafiq M, Simkovich S, Hossen S, Feller-Kopman DJ. Indwelling pleural catheter drainage strategy for malignant effusion: a cost-effectiveness analysis. Ann Am Thorac Soc. 2020;17(6):746\u201353.","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"300_CR61","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1089\/jpm.2020.0695","volume":"24","author":"M Botana-Rial","year":"2020","unstructured":"Botana-Rial M, Ramos-Hern\u00e1ndez C, Lojo-Rodr\u00edguez I, Represas-Represas C, Ruano-Ravi\u00f1a A, Leiro-Fern\u00e1ndez V, et al. Cost-effectiveness of malignant pleural effusion with indwelling catheter: systematic review. J Palliat Med. 2020;24(8):1206\u201312.","journal-title":"J Palliat Med"},{"issue":"1","key":"300_CR62","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s13063-022-06405-7","volume":"23","author":"DB Fitzgerald","year":"2022","unstructured":"Fitzgerald DB, Sidhu C, Budgeon C, Tan AL, Read CA, Kwan BCH, et al. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (\u00b1talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion. Trials. 2022;23(1):530.","journal-title":"Trials"},{"issue":"1","key":"300_CR63","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13063-024-08065-1","volume":"25","author":"EPM Lau","year":"2024","unstructured":"Lau EPM, Ing M, Vekaria S, Tan AL, Charlesworth C, Fysh E, et al. Australasian Malignant PLeural Effusion (AMPLE)-4 trial: study protocol for a multi-centre randomised trial of topical antibiotics prophylaxis for infections of indwelling pleural catheters. Trials. 2024;25(1):249.","journal-title":"Trials"},{"key":"300_CR64","unstructured":"www.isrctn.com\/ISRCTN12371566 accessed 20th March 2025"},{"key":"300_CR65","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT03831386 accessed 20th March 2025"},{"key":"300_CR66","unstructured":"https:\/\/arc-eoe.nihr.ac.uk\/research-implementation\/research-themes\/palliative-and-end-life-care\/pleural-catheters-co accessed 20th March 2025"},{"key":"300_CR67","unstructured":"www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2022-01561 accessed 20th March 2025"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00300-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-025-00300-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00300-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T20:45:29Z","timestamp":1757191529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-025-00300-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s41030-025-00300-7","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Avinash Aujayeb is an Editorial Board member of Pulmonary Therapy. Avinash Aujayeb was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Abdulla Baguneid, Thisarana Wijayaratne, and Rakesh Panchal have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}